|Ask||7.80 x 1000|
|Day's Range||7.46 - 7.72|
|52 Week Range||3.21 - 8.00|
|PE Ratio (TTM)||-7.00|
|Earnings Date||Mar 7, 2017 - Mar 13, 2017|
|Dividend & Yield||0.00 (0.00%)|
|1y Target Est||10.00|
Looking at growth outlooks and price targets, these four small-cap stocks could have a stellar 2017.
Spectrum Pharmaceuticals, Inc. , a biotechnology company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology, announced the presentation of data from a clinical study of FOLOTYN plus Romidepsin in patients with relapsed or refractory Peripheral T-Cell Lymphoma in an oral presentation session which was presented at the 14th International Conference ...
Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Spectrum Pharmaceuticals, Inc. a score of 6. Our analysis is based on comparing Spectrum Pharmaceuticals, Inc. with the following peers – Teva Pharmaceutical Industries Limited Sponsored ADR, Celgene Corporation, Curis, Inc., Seattle Genetics, Inc., Novartis AG Sponsored ADR, Pfizer Inc., Abbott Laboratories, Bristol-Myers Squibb Company, Biogen Inc. ... Read more (Read more...)